Which of the following is not a starting criteria for sulfonylurea therapy ?
**Core Concept**
Sulfonylureas are a class of medications used to treat type 2 diabetes mellitus by stimulating insulin release from the pancreatic beta cells. The selection of patients for sulfonylurea therapy is crucial, and various criteria are used to guide this decision.
**Why the Correct Answer is Right**
Sulfonylureas are contraindicated in patients with a history of hypoglycemic episodes, as they can exacerbate this condition. Sulfonylureas work by binding to and closing ATP-sensitive potassium channels in the pancreatic beta cells, leading to cell depolarization, opening of voltage-gated calcium channels, and ultimately, insulin secretion. However, in patients with a history of hypoglycemia, the risk of severe hypoglycemia increases, making sulfonylureas a poor choice.
**Why Each Wrong Option is Incorrect**
**Option A:** This option does not provide sufficient information to evaluate its correctness.
**Option B:** This option is incorrect because sulfonylureas are often used in patients with a history of cardiovascular disease, as they may have a favorable effect on cardiovascular outcomes.
**Option C:** This option is incorrect because patients with a history of gastrointestinal disease are not necessarily contraindicated for sulfonylurea therapy, although caution may be necessary.
**Clinical Pearl / High-Yield Fact**
Sulfonylureas are not indicated in patients with a history of hypoglycemic episodes, as they can exacerbate this condition and increase the risk of severe hypoglycemia.
**Correct Answer:** A.